These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20709903)

  • 1. Efficient osteoclast differentiation requires local complement activation.
    Tu Z; Bu H; Dennis JE; Lin F
    Blood; 2010 Nov; 116(22):4456-63. PubMed ID: 20709903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow.
    Ratajczak J; Reca R; Kucia M; Majka M; Allendorf DJ; Baran JT; Janowska-Wieczorek A; Wetsel RA; Ross GD; Ratajczak MZ
    Blood; 2004 Mar; 103(6):2071-8. PubMed ID: 14604969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement C3a and C5a modulate osteoclast formation and inflammatory response of osteoblasts in synergism with IL-1β.
    Ignatius A; Schoengraf P; Kreja L; Liedert A; Recknagel S; Kandert S; Brenner RE; Schneider M; Lambris JD; Huber-Lang M
    J Cell Biochem; 2011 Sep; 112(9):2594-605. PubMed ID: 21598302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biological roles of the third component of complement in osteoclast formation.
    Sato T; Abe E; Jin CH; Hong MH; Katagiri T; Kinoshita T; Amizuka N; Ozawa H; Suda T
    Endocrinology; 1993 Jul; 133(1):397-404. PubMed ID: 8319587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation studies in C3-deficient animals reveal a novel role of the third complement component (C3) in engraftment of bone marrow cells.
    Ratajczak MZ; Reca R; Wysoczynski M; Kucia M; Baran JT; Allendorf DJ; Ratajczak J; Ross GD
    Leukemia; 2004 Sep; 18(9):1482-90. PubMed ID: 15284858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement gene expression is regulated by pro-inflammatory cytokines and the anaphylatoxin C3a in human tenocytes.
    Busch C; Girke G; Kohl B; Stoll C; Lemke M; Krasnici S; Ertel W; Silawal S; John T; Schulze-Tanzil G
    Mol Immunol; 2013 Apr; 53(4):363-73. PubMed ID: 23070120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of complement C3, C5, C3aR and C5aR1 genes in resting and activated CD4
    Hansen CB; Willer A; Bayarri-Olmos R; Kemper C; Garred P
    Immunobiology; 2019 Mar; 224(2):307-315. PubMed ID: 30612786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage lineage phenotypes and osteoclastogenesis--complexity in the control by GM-CSF and TGF-beta.
    Lari R; Fleetwood AJ; Kitchener PD; Cook AD; Pavasovic D; Hertzog PJ; Hamilton JA
    Bone; 2007 Feb; 40(2):323-36. PubMed ID: 17055352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand.
    Itoh K; Udagawa N; Katagiri T; Iemura S; Ueno N; Yasuda H; Higashio K; Quinn JM; Gillespie MT; Martin TJ; Suda T; Takahashi N
    Endocrinology; 2001 Aug; 142(8):3656-62. PubMed ID: 11459815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.
    Xing L; Bushnell TP; Carlson L; Tai Z; Tondravi M; Siebenlist U; Young F; Boyce BF
    J Bone Miner Res; 2002 Jul; 17(7):1200-10. PubMed ID: 12096833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel role of complement in retinal degeneration.
    Yu M; Zou W; Peachey NS; McIntyre TM; Liu J
    Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7684-92. PubMed ID: 23074214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Megakaryocyte-mediated inhibition of osteoclast development.
    Kacena MA; Nelson T; Clough ME; Lee SK; Lorenzo JA; Gundberg CM; Horowitz MC
    Bone; 2006 Nov; 39(5):991-999. PubMed ID: 16782418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-1 plays an important role in the bone metabolism under physiological conditions.
    Lee YM; Fujikado N; Manaka H; Yasuda H; Iwakura Y
    Int Immunol; 2010 Oct; 22(10):805-16. PubMed ID: 20679512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoclast precursors in murine bone marrow express CD27 and are impeded in osteoclast development by CD70 on activated immune cells.
    Xiao Y; Song JY; de Vries TJ; Fatmawati C; Parreira DB; Langenbach GE; Babala N; Nolte MA; Everts V; Borst J
    Proc Natl Acad Sci U S A; 2013 Jul; 110(30):12385-90. PubMed ID: 23832783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.
    Kobayashi K; Takahashi N; Jimi E; Udagawa N; Takami M; Kotake S; Nakagawa N; Kinosaki M; Yamaguchi K; Shima N; Yasuda H; Morinaga T; Higashio K; Martin TJ; Suda T
    J Exp Med; 2000 Jan; 191(2):275-86. PubMed ID: 10637272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of RANKL-induced osteoclast formation in mouse bone marrow cells by IL-12: involvement of IFN-gamma possibly induced from non-T cell population.
    Nagata N; Kitaura H; Yoshida N; Nakayama K
    Bone; 2003 Oct; 33(4):721-32. PubMed ID: 14555278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation.
    Karst M; Gorny G; Galvin RJ; Oursler MJ
    J Cell Physiol; 2004 Jul; 200(1):99-106. PubMed ID: 15137062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha.
    Hayashi S; Yamada T; Tsuneto M; Yamane T; Takahashi M; Shultz LD; Yamazaki H
    J Immunol; 2003 Nov; 171(10):5130-9. PubMed ID: 14607912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-3 acts directly on osteoclast precursors and irreversibly inhibits receptor activator of NF-kappa B ligand-induced osteoclast differentiation by diverting the cells to macrophage lineage.
    Khapli SM; Mangashetti LS; Yogesha SD; Wani MR
    J Immunol; 2003 Jul; 171(1):142-51. PubMed ID: 12816992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts.
    Kindle L; Rothe L; Kriss M; Osdoby P; Collin-Osdoby P
    J Bone Miner Res; 2006 Feb; 21(2):193-206. PubMed ID: 16418775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.